{"id":"NCT04308590","sponsor":"Corcept Therapeutics","briefTitle":"A Study of the Efficacy and Safety of Relacorilant in Patients With Cortisol-Secreting Adrenal Adenomas","officialTitle":"Glucocorticoid Receptor Antagonism in the Treatment of Hypercortisolism in Patients With Cortisol-Secreting Adrenal Adenomas or Hyperplasia (GRADIENT): A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Relacorilant","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2020-07-27","primaryCompletion":"2024-09-19","completion":"2024-09-19","firstPosted":"2020-03-16","resultsPosted":"2025-08-03","lastUpdate":"2025-09-04"},"enrollment":137,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Hypercortisolism"],"interventions":[{"type":"DRUG","name":"Relacorilant","otherNames":["CORT125134"]},{"type":"OTHER","name":"Placebo","otherNames":[]}],"arms":[{"label":"Relacorilant","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"This is a Phase 3, randomized, double-blind, placebo-controlled study to assess the efficacy, and safety of relacorilant to treat hypercortisolism in patients with cortisol-secreting adrenal adenoma or hyperplasia associated with diabetes mellitus/ impaired glucose tolerance (DM/IGT) and/or uncontrolled systolic hypertension (HTN).","primaryOutcome":{"measure":"Change in Average 24-hour SBP","timeFrame":"Baseline and Week 22","effectByArm":[{"arm":"Relacorilant","deltaMin":-5.56,"sd":null},{"arm":"Placebo","deltaMin":-2.89,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.4160"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":5},"locations":{"siteCount":45,"countries":["United States","Austria","Bulgaria","Germany","Israel","Italy","Poland","Romania","Spain"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":15,"n":68},"commonTop":["Back pain","Fatigue","Arthralgia","Nausea","Headache"]}}